Subscribe

Shitanshu Uppal

RTOG 90-01 (Morris): Pelvic Radiation + Concurrent Cisplatin/5-FU vs Extended-Field Radiation Alone for Locally Advanced Cervical Cancer

GOG 242: Second Curettage for Low-Risk Nonmetastatic GTN

GOG 174: Weekly Methotrexate vs. Pulsed Dactinomycin for Low-Risk GTN

Publications Update # 142

ASCO update on RUBY and GY018, Mirvetuximab and Cataract risk, and two ASCO posters and an article promoting professional friendships

Trastuzumab in HER2-Positive Uterine Serous Carcinoma (Fader)

ICON4/AGO-OVAR-2.2: Paclitaxel–Platinum vs Platinum in Platinum-Sensitive Relapsed Ovarian Cancer

SORAYA: Mirvetuximab Soravtansine in FRα-High Platinum-Resistant Ovarian Cancer

GOG 85: Cisplatin/5-FU vs Hydroxyurea with Radiation in Locally Advanced Cervical Cancer

GOG 161: Ifosfamide ± Paclitaxel in Advanced Uterine Carcinosarcoma

ASTEC: Pelvic Lymphadenectomy in Endometrial Cancer